100 results
Page 3 of 5
6-K
EX-99.1
i7pjt46xw h7
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
6-K
EX-1.1
ny1p9bbctjzo
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
424B5
ru0e6lhc0ofgrbv
9 Sep 22
Prospectus supplement for primary offering
4:23pm
6-K
EX-99.2
s2ewu
9 Sep 22
Immunocore presents promising initial Phase 1 data for first off-the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress
12:33pm
6-K
EX-99.1
z0rqlycrnd6ns
9 Sep 22
Immunocore presents promising initial Phase 1 data for first off-the-shelf TCR therapy targeting PRAME at the ESMO 2022 Congress
12:33pm
6-K
j22hb
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.3
wioae8k9
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.4
r4tmgyo9j
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
58z80puzqgbf0zqce
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.1
hmlmh8vivhmqakp
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.2
bca2cgrqhas
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.3
d25onfe5 98
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.1
mllu725d1q82j beav
11 Jul 22
Immunocore announces dosing of first patient with ImmTAV® bispecific for HIV
4:05pm
6-K
EX-99.1
0q73uwt6s
27 Jun 22
Current report (foreign)
4:05pm
6-K
EX-99.1
s4jtf 8ap0coygvtxql
9 Jun 22
Immunocore Appoints Siddharth Kaul to its Board of Directors
4:12pm
6-K
EX-99.1
ojn8x0th5ptn4 cw961z
8 Jun 22
KIMMTRAK is the first and only treatment approved in the UK, Australia, and Canada to treat patients with unresectable or metastatic uveal melanoma
4:06pm
6-K
EX-99.1
hl155oeu8m592jd4haje
6 Jun 22
Immunocore presents new data on KIMMTRAK (tebentafusp-tebn) in metastatic
4:21pm
6-K
EX-99.1
lji5d62u0c daoq4etm
3 Jun 22
Sanofi will evaluate KIMMTRAK in combination with SAR444245 as part of its ongoing Phase 1 study in advanced unresectable or metastatic skin cancers
4:05pm
6-K
EX-99.3
7ld matp1ynnn4wmxx
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am
6-K
noh7r2pko m6xnz
11 May 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:08am